$2.43T
Total marketcap
$71.17B
Total volume
BTC 50.78%     ETH 15.61%
Dominance

ANI Pharmaceuticals ANIP Stock

66.88 USD {{ price }} -1.805907% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
1.4B USD
LOW - HIGH [24H]
66.41 - 67.98 USD
VOLUME [24H]
94.98K USD
{{ volume }}
P/E Ratio
78.68
Earnings per share
0.85 USD

ANI Pharmaceuticals Price Chart

ANI Pharmaceuticals ANIP Financial and Trading Overview

ANI Pharmaceuticals stock price 66.88 USD
Previous Close 49.67 USD
Open 49.5 USD
Bid 0 USD x 1000
Ask 0 USD x 900
Day's Range 49.47 - 51.25 USD
52 Week Range 23.09 - 52.23 USD
Volume 131.37K USD
Avg. Volume 109.25K USD
Market Cap 1.02B USD
Beta (5Y Monthly) 1.027464
PE Ratio (TTM) N/A
EPS (TTM) 0.85 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 52.4 USD

ANIP Valuation Measures

Enterprise Value 1.08B USD
Trailing P/E N/A
Forward P/E 11.793022
PEG Ratio (5 yr expected) 6.9
Price/Sales (ttm) 2.8482192
Price/Book (mrq) 2.6726043
Enterprise Value/Revenue 3.019
Enterprise Value/EBITDA 16.79

Trading Information

ANI Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.027464
52-Week Change 107.99%
S&P500 52-Week Change 20.43%
52 Week High 52.23 USD
52 Week Low 23.09 USD
50-Day Moving Average 42.91 USD
200-Day Moving Average 40.02 USD

ANIP Share Statistics

Avg. Volume (3 month) 109.25K USD
Avg. Daily Volume (10-Days) 109.82K USD
Shares Outstanding 20.15M
Float 12.29M
Short Ratio 1.43
% Held by Insiders 13.51%
% Held by Institutions 73.43%
Shares Short 255.62K
Short % of Float 1.92%
Short % of Shares Outstanding 1.27%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -7.34%
Operating Margin (ttm) 1.30%
Gross Margin 60.35%
EBITDA Margin 17.97%

Management Effectiveness

Return on Assets (ttm) 0.38%
Return on Equity (ttm) -7.67%

Income Statement

Revenue (ttm) 358.69M USD
Revenue Per Share (ttm) 21.97 USD
Quarterly Revenue Growth (yoy) 65.60%
Gross Profit (ttm) 177.6M USD
EBITDA 64.49M USD
Net Income Avi to Common (ttm) -28066000 USD
Diluted EPS (ttm) -1.75
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 67.76M USD
Total Cash Per Share (mrq) 4.09 USD
Total Debt (mrq) 286.31M USD
Total Debt/Equity (mrq) 84.34 USD
Current Ratio (mrq) 2.899
Book Value Per Share (mrq) 18.974

Cash Flow Statement

Operating Cash Flow (ttm) 9.16M USD
Levered Free Cash Flow (ttm) 15.99M USD

Profile of ANI Pharmaceuticals

Country United States
State MN
City Baudette
Address 210 Main Street West
ZIP 56623
Phone 218 634 3500
Website https://www.anipharmaceuticals.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 600

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Q&A For ANI Pharmaceuticals Stock

What is a current ANIP stock price?

ANI Pharmaceuticals ANIP stock price today per share is 66.88 USD.

How to purchase ANI Pharmaceuticals stock?

You can buy ANIP shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ANI Pharmaceuticals?

The stock symbol or ticker of ANI Pharmaceuticals is ANIP.

Which industry does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.

How many shares does ANI Pharmaceuticals have in circulation?

The max supply of ANI Pharmaceuticals shares is 20.98M.

What is ANI Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

ANI Pharmaceuticals PE Ratio is 78.68235000 now.

What was ANI Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

ANI Pharmaceuticals EPS is 0.85 USD over the trailing 12 months.

Which sector does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals sector is Healthcare.

ANI Pharmaceuticals ANIP included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16175.09 USD
-1.62
3.94B USD 16125.33 USD 16341.46 USD 3.94B USD
NASDAQ Global Market Composite NQGM 2160.36 USD
-2.45
2147.48 USD 2200.33 USD
NASDAQ Biotechnology NBI 4195.13 USD
-2.14
4174.1 USD 4266.29 USD
NASDAQ HealthCare IXHC 958.68 USD
-2.07
954.08 USD 972.42 USD
NASDAQ Composite Total Return I XCMP 19659.36 USD
-1.62
19598.88 USD 19861.56 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Biotechnology Total Retu XNBI 4501.69 USD
-2.14
4479.13 USD 4578.05 USD